NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in ...

Image Source: Zacks Investment Research Spikevax, targeting the variant JN.1., is currently approved in the United States, the United Kingdom, Japan and Taiwan. Last month, the FDA approved ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved an adapted Moderna COVID-19 vaccine (Spikevax) that targets the JN.1 COVID-19 subvariant. This vaccine is licensed for ...

Elon Musk’s antics never cease as he posts yet another artificially generated image of presidential candidate Kamala Harris. X users seem to think that Musk has gone too far this time. Devout Trump ...

For the first time in the UK, the updated vaccine, Spikevax® JN.1, will also be available to purchase privately for those who are not eligible for the NHS Autumn vaccination program. The updated ...

In the month, the US regulatory agency approved and granted EUAs to two updated mRNA vaccines, namely Moderna’s Spikevax and Pfizer / BioNTech’s Comirnaty. Both mRNA vaccines were approved for ...

has approved an updated formulation of the COVID-19 mRNA vaccine Spikevax, targeting the SARS-CoV-2 variant JN.1., for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals ...

The only reason the image looks a little fuzzy around the edges is not because the resolution is poor, but because atoms don't stop jiggling about, which results in a little thermal motion blur. No ...

Novavax's traditional protein-based shot offers an alternative vaccine technology to those that are based on messenger RNA - Moderna's Spikevax and Comirnaty, which is jointly developed by Pfizer ...